Annexon, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
ANNX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1400 Sierra Point Parkway, Bldg C, Suite 200, Brisbane, CA

Insiders trading volume in the past year

Annexon, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Muneer A. Satter Director, 10%+ Owner $33.5M +$1.01M +3.1% Jun 5, 2024
Bain Capital Life Sciences Investors, LLC 10%+ Owner $24.4M May 25, 2023
Douglas Love PRESIDENT AND CEO, Director $575K -$32K -5.28% Oct 30, 2024
Michael Overdorf Evp & Chief Business Officer $570K -$22.9K -3.86% Jul 15, 2024
Ted Yednock Evp & Chief Innovation Officer $529K -$391K -42.5% Oct 15, 2024
Jennifer Lew Evp & Chief Financial Officer $521K -$31K -5.61% Jul 15, 2024
Dean Richard Artis Evp & Chief Scientific Officer $494K Feb 16, 2024
Jamie Dananberg Chief Medical Officer $216K Feb 16, 2024
William H. Carson Director $136K +$140K Dec 2, 2024
Larry Mattheakis EVP & Chief Scientific Officer $77.7K Jul 11, 2022
Sanjay Keswani EVP & Chief Medical Officer $56.5K Feb 11, 2022
Bettina M. Cockroft Director Jun 5, 2024
William D. Waddill Director Jun 5, 2024
Ricky Sun Director Jun 2, 2021
Thomas G. Wiggans Director Jun 5, 2024
Jung Choi Director Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Annexon, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.